These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 9210895)
1. Three decades' experience in surgery of hepatocellular carcinoma. Tang ZY; Yu YQ; Zhou XD; Yang BH; Lin ZY; Lu JZ; Ma ZC; Ye SL; Liu KD Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():126-33. PubMed ID: 9210895 [TBL] [Abstract][Full Text] [Related]
2. Surgical treatment of hepatocellular carcinoma and related basic research with special reference to recurrence and metastasis. Tang Z; Zhou X; Lin Z; Yang B; Ma Z; Ye S; Wu Z; Fan J; Liu Y; Liu K; Qin L; Tian J; Sun H; He B; Xia J; Qiu S; Zhou J Chin Med J (Engl); 1999 Oct; 112(10):887-91. PubMed ID: 11717970 [TBL] [Abstract][Full Text] [Related]
3. Progress and prospects in hepatocellular carcinoma surgery. Tang ZY; Yu YQ; Zhou XD; Ma ZC; Wu ZQ Ann Chir; 1998; 52(6):558-63. PubMed ID: 9752506 [TBL] [Abstract][Full Text] [Related]
4. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma]. Fan J; Wu Z; Tang Z Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184 [TBL] [Abstract][Full Text] [Related]
5. Downstaging followed by resection plays a role in improving prognosis of unresectable hepatocellular carcinoma. Tang ZY; Zhou XD; Ma ZC; Wu ZQ; Fan J; Qin LX; Yu Y Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):495-8. PubMed ID: 15567731 [TBL] [Abstract][Full Text] [Related]
6. Multimodality treatment in advanced primary liver cancer. Zhou XD; Tang ZY; Yu YQ; Yang BH; Lu JZ; Lin ZY; Ma ZC Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():286-9. PubMed ID: 7544966 [TBL] [Abstract][Full Text] [Related]
7. [Surgical treatment of 1450 patients with hepatocellular carcinoma]. Tang ZY Zhonghua Wai Ke Za Zhi; 1992 Jun; 30(6):325-8, 381. PubMed ID: 1337509 [TBL] [Abstract][Full Text] [Related]
8. Analysis of one hundred and twenty five patients with primary liver cancer surviving more than five years. Tang ZY; Yu YQ; Zhou XD; Ma ZC; Yang BH; Lu JZ; Lin HY; Tang CL Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1202-6. PubMed ID: 1514834 [TBL] [Abstract][Full Text] [Related]
9. [Long-term results of multimodality treatment in patients with primary liver cancer]. Zhou X; Tang Z; Yu Y Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):518-21. PubMed ID: 9594152 [TBL] [Abstract][Full Text] [Related]
10. Longterm prognosis after hepatic resection for small hepatocellular carcinoma. Shimozawa N; Hanazaki K J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736 [TBL] [Abstract][Full Text] [Related]
11. [Surgery-predominant comprehensive therapy for 134 patients with small hepatocellular carcinoma]. Mo QG; Liang AM; Yang NW; Zhao YN; Yuan WP Ai Zheng; 2003 Feb; 22(2):189-91. PubMed ID: 12600298 [TBL] [Abstract][Full Text] [Related]
12. [Appraisal of postoperative transcatheter arterial chemoembolization (TACE) for prevention and treatment of hepatocellular carcinoma recurrence]. Lin Z; Ren Z; Xia J Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):315-7. PubMed ID: 11778559 [TBL] [Abstract][Full Text] [Related]
13. Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience. Yamashita Y; Taketomi A; Itoh S; Kitagawa D; Kayashima H; Harimoto N; Tsujita E; Kuroda Y; Maehara Y J Am Coll Surg; 2007 Jul; 205(1):19-26. PubMed ID: 17617328 [TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of recurrent hepatocellular carcinoma. Zhou XD; Yu YQ; Tang ZY; Yang BH; Lu JZ; Lin ZY; Ma ZC; Xu DB; Zhang BH; Zheng YX Hepatogastroenterology; 1993 Aug; 40(4):333-6. PubMed ID: 8406302 [TBL] [Abstract][Full Text] [Related]
15. [Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature]. Neeff H; Makowiec F; Harder J; Gumpp V; Klock A; Thimme R; Drognitz O; Hopt UT Zentralbl Chir; 2009 Apr; 134(2):127-35. PubMed ID: 19382043 [TBL] [Abstract][Full Text] [Related]
16. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Cherqui D; Laurent A; Mocellin N; Tayar C; Luciani A; Van Nhieu JT; Decaens T; Hurtova M; Memeo R; Mallat A; Duvoux C Ann Surg; 2009 Nov; 250(5):738-46. PubMed ID: 19801927 [TBL] [Abstract][Full Text] [Related]
17. Management of hepatocellular carcinoma: long-term outcome in 2639 cases. Zhou XD; Tang ZY Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():9-16. PubMed ID: 9210883 [TBL] [Abstract][Full Text] [Related]
18. [Small hepatocellular carcinoma (HCC) and its remote outcome]. Tang ZY; Yu YQ Zhonghua Zhong Liu Za Zhi; 1987 Mar; 9(2):118-20. PubMed ID: 2820680 [TBL] [Abstract][Full Text] [Related]
19. Fibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series. Bhaijee F; Locketz ML; Krige JE S Afr J Surg; 2009 Nov; 47(4):108-11. PubMed ID: 20141066 [TBL] [Abstract][Full Text] [Related]
20. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection. Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]